Use of AHRQ’s Preventable Hospitalization Costs and Mapping Tool Brooks Daverman...

Use of AHRQ’s

Preventable Hospitalization Costs

and Mapping Tool Brooks Daverman

[email protected]

Tennessee Division of Health Planning

2

State Healthcare Report Card

Version 2 coming soonDiabetes, hypertension and…

asthmaCounty-level maps

3

Purpose of Report

Motivated by high levels of chronic disease in Tennessee.

Pulls together all available data. Presents at as local a level as

possible.First step toward all-payer claims

database.

DHHS

Reformatted as bullet list.

4

Report Combines 3 Types of Data

BRFSS survey data.HEDIS measures voluntarily

submitted by TN health plans and TennCare (TN Medicaid).

AHRQ mapping tool using hospital discharge data.

5

BRFSS

Have you ever been told by a doctor that you have diabetes? (2008)

8.3 – 8.9%

9.0 – 10.5%

10.6 – 10.9%

11.0 – 12.0%

12.1 – 14.0%

6

Screening Measures

HbA1c testing rates – diabetes 71.31-91.41%

LDL-C screening rates – diabetes 64.72-87.55%

LDL-C screening rates – cardiovascular conditions 60.26-87.20%

7

HEDIS Measure Example

HbA1c Testing Rates Among Patients With Diabetes

77.74 – 82.73%

82.74 – 84.15%

84.16 – 85.46%

85.47 – 86.97%

86.98 – 89.08%

8

Other County-Level HEDIS Data in Report

LDL-C Screening Rates Patients with diabetes Patients with cardiovascular conditions

Rates of Use of Appropriate Medication for People With Asthma Ages 5-9 years Ages 10-17 years Ages 18-56 years Total rates

9

Statewide HEDIS Data in Report

HEDIS 2009 TN Health Plan Average vs. HEDIS 2009 National Averages

Commercial HMO Medicaid HMO

HEDIS 2009TN

HEDIS 2009National

HEDIS 2009TN

HEDIS 2009National

HbA1c Poor Control (>9.0%) - Patients With Diabetes* 26.0% 28.4% 47.3% 44.8%

LDL-C Control (<100 mg/dL) - Patients With Diabetes 40.8% 45.5% 26.0% 33.8%

Blood Pressure Control (<130/80 mm Hg) - Patients With Diabetes 29.7% 33.4% 31.2% 30.7%

Blood Pressure Control (<140/90 mm Hg) - Patients With Diabetes 67.2% 65.6% 56.7% 56.9%

Blood Pressure Control (<140/90 mm Hg) - Patients With Hypertension 61.3% 63.4% 52.8% 55.8%

LDL-C Control (<100 mg/dL) - Patients With Cardiovascular Conditions 56.2% 59.7% 42.8% 40.1%

Use of AHRQ’s Preventable Hospitalization Costs and Mapping Tool Brooks Daverman...

Documents

Transcript of Use of AHRQ’s Preventable Hospitalization Costs and Mapping Tool Brooks Daverman...